β2-microglobulin modified with advanced glycation end products delays monocyte apoptosis

Fan Fan Hou, Toshio Miyata, Joshua Boyce, Qian Yuan, Glenn M. Chertow, Jonathan Kay, Ann Marie Schmidt, William F. Owen

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Background. A local inflammatory reaction to β2-microglobulin (β2m) amyloid deposits by monocytes/macrophages is a characteristic histologic feature of dialysis-related amyloidosis (DRA). Since β2m modified with advanced glycation end products (AGE-β2m) is a major constituent of amyloid in DRA, we tested the hypothesis that AGE-β2m affects apoptosis and phenotype of human monocytes. Methods. Human peripheral blood monocytes were incubated with or without in vitro-derived AGE-β2m, and their viability, extent of apoptosis, morphology, and function examined over the subsequent four days. Results. AGE-modified but not unmodified β2m significantly delayed spontaneous apoptosis of human peripheral blood monocytes in adherent and nonadherent cultures. The effect of AGE-β2m on monocytes apoptosis was time- and dose-dependent and was attenuated by a blocking antibody directed against the human AGE receptor (RAGE). There was no difference in effect between AGE-β2m and that of AGE-modified human serum albumin. Culture of monocytes with AGE-β2m did not alter membrane expression of Fas or Fas ligand. Monocytes cultured with AGE-β2m underwent substantial changes in morphology similar to those observed when monocytes differentiate into macrophages. The cultured cells increased in size and vacuolization, and their content of β-glucuronidase and acid phosphatase increased by 5- to 10-fold at day 4. Expression of the monocyte-macrophage membrane antigens HLA-DR, CD11b, and CD11c also increased at day 4. Although exhibiting phenotypic characteristics of macrophages, monocytes cultured with AGE-β2m functioned differently than macrophages cultured with serum. Superoxide production in response to phorbol myristic acetate was maintained in monocytes cultured with AGE-β2m, but declined with time in cells cultured with serum. Constitutive synthesis of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and prostaglandin E2 (PGE2) increased in monocytes cultured for four to six days with AGE-β2m. Conclusions. These findings support a novel role for AGE modified proteins such as AGE-β2m that may contribute to the development of a local inflammatory response, with predominant accumulation of monocytes/macrophages, in DRA.

Original languageEnglish
Pages (from-to)990-1002
Number of pages13
JournalKidney international
Volume59
Issue number3
DOIs
Publication statusPublished - 2001 Jan 1
Externally publishedYes

Keywords

  • Amyloidosis
  • Cell death
  • Chronic renal failure
  • Dialysis
  • Inflammation

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'β<sub>2</sub>-microglobulin modified with advanced glycation end products delays monocyte apoptosis'. Together they form a unique fingerprint.

  • Cite this

    Hou, F. F., Miyata, T., Boyce, J., Yuan, Q., Chertow, G. M., Kay, J., Schmidt, A. M., & Owen, W. F. (2001). β2-microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney international, 59(3), 990-1002. https://doi.org/10.1046/j.1523-1755.2001.059003990.x